News Arbuthnot backs Nova acquisition of Shakespeare with £5.92m ABL facility Arbuthnot Commercial Asset Based Lending (ACABL) has provided a £5.92 million asset-based lending (ABL) facility to support Nova Capital Management’s acquisition of Shakespeare Monofilament UK Ltd as part of its purchase of both Shakespeare Company LLC and Shakespeare Monofilament UK. The funding package, ACABL’s first transaction with Nova Capital Management, comprises a £2.5 million Confidential […]